01 Expansion of State-Licensed Cannabis Retail Networks The legalized cannabis market is shifting toward broader and more accessible licensed retail networks as jurisdictions increase the number of approved dispensaries and expand geographic coverage. This is improving consumer access to regulated products and strengthening the commercial infrastructure required for legal-market participation. In April 2026, the New Jersey Cannabis Regulatory Commission reported that more than 300 licensed dispensaries were operating across the state, compared with 240 dispensaries open to the public in May 2025.
02 Increasing Formalization of Medical Cannabis Regulatory Frameworks Medical cannabis markets are increasingly being subject to structured regulatory reviews as governments assess how existing frameworks affect patients, healthcare professionals, manufacturers, and importers. This is encouraging greater scrutiny of product access, prescribing arrangements, manufacturing controls, and the long-term role of cannabis-based medicines within healthcare systems. In September 2025, the UK's Advisory Council on the Misuse of Drugs launched a review of the 2018 regulatory changes governing cannabis-based products for medicinal use, including their intended effects and unintended consequences.
01 Growing Acceptance of Cannabis-Based Products Expands the Potential Consumer Base Changing social attitudes toward cannabis and increasing awareness of its potential medical and wellness applications are broadening the population willing to consider legal cannabis products. Greater familiarity with cannabis-based products for therapeutic and wellness purposes is encouraging consumers to explore different product categories and supporting sustained demand across the legalized cannabis market.
01 High Tax and Compliance Costs Reduce Price Competitiveness of Licensed Cannabis Licensed cannabis businesses must absorb costs associated with taxation, licensing, testing, tracking, security, and regulatory compliance. These expenses can increase final product prices relative to unregulated alternatives, making it more difficult for legal operators to compete on price in mature markets.
01 Development of Cannabis Consumption Areas Creates New Licensed Revenue Channels Legal markets are expanding beyond conventional dispensary sales by permitting regulated locations where adults can consume cannabis purchased through licensed businesses. These venues create opportunities for retailers and other licensed operators to develop differentiated customer experiences and generate additional commercial activity around legal cannabis consumption.
01 Competition From Unlicensed Cannabis Sales Continues to Undermine Legal-Market Conversion Licensed operators continue to compete with businesses selling cannabis outside regulated channels. Unlicensed products can avoid testing, labeling, taxation, and other compliance expenses, creating a price and accessibility advantage that can slow the conversion of consumers from informal markets to regulated purchasing channels.
May 2026 Tilray Brands expanded its medical cannabis portfolio in Europe by launching new cannabis-based therapeutic products and strengthening distribution across key European markets.
March 2026 Curaleaf Holdings expanded its retail footprint through the opening of new licensed cannabis dispensaries in the United States, increasing access to medical and adult-use cannabis products.
March 2026 Curaleaf Holdings expanded its retail footprint through the opening of new licensed cannabis dispensaries in the United States, increasing access to medical and adult-use cannabis products.
June 2025 Aurora Cannabis expanded its international medical cannabis operations by launching additional products in Germany following evolving regulatory frameworks.